InsiderSignal.AI

InsiderSignal.ai

TXG - 10X Genomics, Inc.

Insider Sale by Saxonov Serge (CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Saxonov Serge, serving as CEO at 10X Genomics, Inc. (TXG), sold 5,000 shares at $24.56 per share, for a total transaction value of $122,784.00. Following this transaction, Saxonov Serge now holds 1,452,194 shares of TXG.

The trade was executed on Tuesday, April 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 16, 2026, 2 days after the trade was made.

10X Genomics, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Saxonov Serge

CEO

Serge Saxonov is the co-founder and CEO of 10x Genomics, Inc. (TXG), a company specializing in single cell and spatial biology technologies aimed at accelerating the mastery of biology to advance human health.[[1]](https://www.youtube.com/watch?v=Up5Udmkpv6o)[[3]](https://www.10xgenomics.com/company/team/serge-saxonov)[[4]](https://pmwcintl.com/speaker/serge-saxonov-286_x-genomics_2026sv/) He co-founded the company in 2012 with Ben Hindson and Kevin Ness, defining its vision and strategy, contributing to core inventions, and leading it from an early-stage startup through rapid growth to its Nasdaq public debut (TXG).[[1]](https://www.youtube.com/watch?v=Up5Udmkpv6o)[[2]](https://www.allamericanspeakers.com/celebritytalentbios/Serge+Saxonov/437106)[[3]](https://www.10xgenomics.com/company/team/serge-saxonov) Under his leadership, 10x has delivered groundbreaking products cited in over 10,000 high-impact publications, enabling discoveries across life sciences.[[3]](https://www.10xgenomics.com/company/team/serge-saxonov)[[4]](https://pmwcintl.com/speaker/serge-saxonov-286_x-genomics_2026sv/) Prior to 10x Genomics, Saxonov served as Vice President of Applications at QuantaLife (acquired by Bio-Rad in 2011), where he built products, drove applications for droplet digital PCR (ddPCR) technology, and identified diagnostics opportunities.[[1]](https://www.youtube.com/watch?v=Up5Udmkpv6o)[[2]](https://www.allamericanspeakers.com/celebritytalentbios/Serge+Saxonov/437106)[[3]](https://www.10xgenomics.com/company/team/serge-saxonov) He was the first employee and Founding Architect/Director of R&D at 23andMe, defining its initial product concept, building core technology, and executing R&D strategy.[[1]](https://www.youtube.com/watch?v=Up5Udmkpv6o)[[2]](https://www.allamericanspeakers.com/celebritytalentbios/Serge+Saxonov/437106)[[5]](https://www.genengnews.com/topics/omics/space-race-10x-ceo-serge-saxonov-discusses-single-cell-and-spatial-biology-on-close-to-the-edge/) Saxonov holds a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics (and biology) from Harvard College.[[1]](https://www.youtube.com/watch?v=Up5Udmkpv6o)[[2]](https://www.allamericanspeakers.com/celebritytalentbios/Serge+Saxonov/437106)[[3]](https://www.10xgenomics.com/company/team/serge-saxonov) His achievements include recognition as one of Goldman Sachs' '100 Most Intriguing Entrepreneurs' in 2016 and San Francisco Business Times' 'Most Admired CEOs' in 2021.[[2]](https://www.allamericanspeakers.com/celebritytalentbios/Serge+Saxonov/437106)[[3]](https://www.10xgenomics.com/company/team/serge-saxonov)[[4]](https://pmwcintl.com/speaker/serge-saxonov-286_x-genomics_2026sv/)

View full insider profile →

Trade Price

$24.56

Quantity

5,000

Total Value

$122,784.00

Shares Owned

1,452,194

Trade Date

Tuesday, April 14, 2026

3 days ago

SEC Filing Date

Thursday, April 16, 2026

Filed 2 days after trade

HEALTHCAREHEALTH INFORMATION SERVICES

About 10X Genomics, Inc.

Company Overview

No company information available
View news mentioning TXG

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5693643

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime